Revance Therapeutics, Inc.

Analyst - Needham
All forecasts
Forecast date: 14.08.2023
Expiration date: 13.08.2024
Start price: 18.5 $
Price target: 40 $
Closing price: 3.32 $
Current price: 3.25 $
Closing price 3.32 $ didn't reach the target 40 $ (-91.7%)

Detailed forecast is available by subscription


Subscribe